The global Bruton's Tyrosine Kinase (BTK) inhibitor market was valued at approximately USD 12.6 billion in 2024 and is projected to reach USD 31.9 billion by 2034, expanding at a Compound 19.9% per year growth (CAGR) for the course of the forecast.
April 28, 2025